文献速递产科母胎医学

孕早期预测早产型子痫前期及阿司匹林预防对自发性与医源性早产的影响

First-trimester prediction of preterm pre-eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth.
PubMed 文献 · BJOG · 2023-09-25

基于SPREE研究与ASPRE试验数据的二次分析,在16451例单胎妊娠中比较FMF三联试验与NICE指南对早产型子痫前期的预测效能及阿司匹林对早产的预防作用。FMF三联试验对自发性早产和子痫前期以外原因医源性早产的预测均较差,NICE指南更差;阿司匹林对上述两类早产无实质性降低。

要点

  • FMF三联试验对自发性早产检出率17%,NICE指南为12%(假阳性率均10.2%)。
  • 阿司匹林估计可预防14%自发性早产、65%子痫前期医源性早产、0%其他原因医源性早产。
  • FMF三联试验对子痫前期以外原因医源性早产检出率25%,NICE指南为19%。

核心结论

  • FMF三联试验对自发性早产和子痫前期以外原因医源性早产的预测较差,NICE指南更差;阿司匹林对自发性早产和子痫前期以外原因医源性早产均无实质性降低。

研究设计与样本

  • SPREE研究与ASPRE试验数据的二次分析,多中心研究。
  • SPREE中单胎妊娠妇女在孕11-13周接受FMF方法与NICE指南筛查早产型子痫前期,16451例妊娠≥24周分娩者用于评估两种方法对早产的预测效能。
  • ASPRE试验结果用于在SPREE人群中检验阿司匹林预防早产的效果。

主要发现

  • 自发性早产、子痫前期医源性早产、子痫前期以外原因医源性早产的估计发生率分别为3.4%、0.8%、1.6%。
  • 在总体筛查阳性率均为10.2%时,FMF三联试验对上述三类早产的检出率分别为17%、82%、25%,NICE指南分别为12%、39%、19%。
  • 阿司匹林估计可预防上述三类早产的比例分别为14%、65%、0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the predictive performance for preterm birth (PTB) of the Fetal Medicine Foundation (FMF) triple test and National Institute for health and Care Excellence (NICE) guidelines used to screen for pre-eclampsia and examine the impact of aspirin in the prevention of PTB. DESIGN: Secondary analysis of data from the SPREE study and the ASPRE trial. SETTING: Multicentre studies. POPULATION: In SPREE, women with singleton pregnancies had screening for preterm pre-eclampsia at 11-13 weeks of gestation by the FMF method and NICE guidelines. There were 16 451 pregnancies that resulted in delivery at ≥24 weeks of gestation and these data were used to derive the predictive performance for PTB of the two methods of screening. The results from the ASPRE trial were used to examine the effect of aspirin in the prevention of PTB in the population from SPREE. METHODS: Comparison of performance of FMF method and NICE guidelines for pre-eclampsia in the prediction of PTB and use of aspirin in prevention of PTB. MAIN OUTCOME MEASURE: Spontaneous PTB (sPTB), iatrogenic PTB for pre-eclampsia (iPTB-PE) and iatrogenic PTB for reasons other than pre-eclampsia (iPTB-noPE). RESULTS: Estimated incidence rates of sPTB, iPTB-PE and iPTB-noPE were 3.4%, 0.8% and 1.6%, respectively. The corresponding detection rates were 17%, 82% and 25% for the triple test and 12%, 39% and 19% for NICE guidelines, using the same overall screen positive rate of 10.2%. The estimated proportions prevented by aspirin were 14%, 65% and 0%, respectively. CONCLUSION: Prediction of sPTB and iPTB-noPE by the triple test was poor and poorer by the NICE guidelines. Neither sPTB nor iPTB-noPE was reduced substantially by aspirin.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Nicolaides KH, Syngelaki A, Poon LC, et al. First-trimester prediction of preterm pre-eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth. BJOG. 2023. PMID: 37749709. doi:10.1111/1471-0528.17673

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。